Detalhe da pesquisa
1.
Emerging Co-Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization.
Adv Mater
; 36(23): e2314095, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344832
2.
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.
Biomaterials
; 309: 122584, 2024 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735180
3.
Minimalist Nanovaccine with Optimized Amphiphilic Copolymers for Cancer Immunotherapy.
ACS Nano
; 18(4): 3349-3361, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230639
4.
Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits.
ACS Nano
; 17(18): 18089-18102, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669546
5.
Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
J Control Release
; 363: 43-56, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734673
6.
X-ray-Induced Release of Nitric Oxide from Hafnium-Based Nanoradiosensitizers for Enhanced Radio-Immunotherapy.
Adv Mater
; 35(29): e2302220, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178454
7.
Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
Adv Mater
; 35(45): e2306281, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722134
8.
Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment.
Sci Adv
; 9(4): eabq3104, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706184
9.
Granzyme B Turns Nanoparticle Fluorescence "On" for Imaging Cytotoxic T Lymphocyte Activity in Vivo.
ACS Nano
; 16(11): 19328-19334, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282211